Navigation Links
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
Date:7/30/2009

o received ANA773 at 1600 mg. Anadys expects to present further results from this study later this year and intends to explore partnership opportunities as a potential path to continue the development of ANA773.
  • Reported PK/PD Data for ANA773 in HCV at EASL. In April 2009, the pharmacokinetic (PK) and pharmacodynamic (PD) data from the healthy volunteer portion of the Phase I clinical trial of ANA773 in HCV were reported at the EASL conference. ANA773 was generally well tolerated with no serious adverse events. Plasma drug levels were proportional to dose, and there was a dose-dependent induction of well-recognized interferon dependent biomarkers.
  • Phase I Clinical Trial in Oncology. In order to focus its resources on ANA598, Anadys recently elected to stop enrollment of new patients in the ongoing Phase I oncology trial of ANA773. Anadys plans for currently enrolled patients to continue to receive ANA773 until disease progression is observed and to conclude the trial once all patients reach this point.
  • Webcast of Conference Call

    Anadys will host a conference call at 5:00 pm Eastern Daylight Time today to discuss its second quarter 2009 financial results and highlights and to provide an update on its development programs. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 85411914. The webcast and telephone replay will be available through August 13, 2009.

    About Anadys

    Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of
    '/>"/>

    SOURCE Anadys Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
    2. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
    3. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
    4. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
    5. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
    6. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
    7. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
    8. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
    9. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
    10. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
    11. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... Tigard, OR and Hershey, PA (PRWEB) December 19, ... (OTC Pink: BJCT), a leading developer and manufacturer ... has entered into an agreement with Immunomic Therapeutics, ... Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ ... receives an option for an exclusive Worldwide license ...
    (Date:12/19/2014)... (PRWEB) December 19, 2014 BioPlus ... specialty pharmacies, announces the promotion of Nick Maroulis, Pharm.D. ... Specialty Pharmacy Services. , In this position, Dr. ... while also managing the directors of our multi-site pharmacies ... BioPlus since 1997 and during that time he has ...
    (Date:12/19/2014)... , Dec. 19, 2014  Roche (SIX: RO, ROG; ... Technologies, Inc. (Bina), a privately held company based ... USA. Bina provides a big data platform for ... (NGS) data. Bina,s proprietary on-market Genomic Management Solution, ... researchers to perform fast and scalable analyses to ...
    (Date:12/19/2014)... Dec. 19, 2014 Decision Resources Group finds ... at a 12 percent compound annual growth rate through ... aging population and the increasing adoption of dental implants. ... will also spur demand for dental biomaterials because ... and periodontal treatments. Other key findings from ...
    Breaking Biology Technology:Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
    ... - The challenges and opportunities that Wisconsin technology ... of in-depth economic development presentations at the eForum ... eInnovate , a local technology networking association. , ... innovation and technology in Wisconsin's economic future by ...
    ... shared with you my observations on the French technology market. ... two and a half days talking to technology companies in ... a fascinating experience, as always. , ,Much of the visit ... make about Israel. Let me start by saying that even ...
    ... MILWAUKEE-- Hal Leonard Corporation , (HLC) headquartered in ... MakeMusic! Inc. , the leading music education technology company, ... popular books for beginning music students: Essential Elements 2000 ... Strings Book 1. , ,SmartMusic is technology-based music ...
    Cached Biology Technology:High-Tech Economic Development in Southeastern Wisconsin 2High-Tech Economic Development in Southeastern Wisconsin 3The Search for new Global Technologies 2The Search for new Global Technologies 3
    (Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
    (Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ... the condition and the best ways to treat it. ...
    (Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
    Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
    ... evidence supporting a harmful effect of exercise on joints in ... a review of studies published in this month,s issue of ... extremely popular leisure-time activity in many countries throughout the Western ... lifestyle. It is widely promoted in as being beneficial for ...
    ... Cold Spring Harbor Laboratory (CSHL) announced today the discovery ... same time, they reported that their discovery suggests the ... processing in which these and possibly other small RNAs ... multinational project called ENCODE, also provided information concerning the ...
    ... 2009 -- Across the globe, the demand for water ... Expanding urban areas are requiring more water for drinking, ... water supplies. In addition, depleting ground water, longer droughts, ... an increased importance for the agricultural industry to optimize ...
    Cached Biology News:CSHL scientists find a new class of small RNAs and define its function 2CSHL scientists find a new class of small RNAs and define its function 3How to move agriculture forward with limited water 2
    Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
    Request Info...
    Myt 1 (N-17)...
    ... by their capacity to self renew and ... progenitor cells, which can commit to further ... (NSCs) are capable of differentiating into multiple ... During the isolation and expansion of NSCs, ...
    Biology Products: